| BCBS Florida Coverage Guidelines | Telisotuzumab Vedotin (Emrelis) IV infusion (09-J5000-24) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Tildrakizumab-asmn (Ilumya®) Injection (09-J3000-04) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Tofacitinib (Xeljanz®, Xeljanz® XR) Oral (09-J1000-86) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Treatments for Varicose Veins/Venous (02-33000-31) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Upadacitinib Tablets (Rinvoq®) and Oral (09-J3000-51) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Ustekinumab Products (Stelara® and (09-J1000-16) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Vedolizumab (Entyvio®) Injection and (09-J2000-18) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Viscosupplementation, Hyaluronan Injections (09-J1000-22) | 2026-01-01 |
| BCBS Illinois Medical Policies | Aflibercept and Associated Biosimilar(s) | 2026-01-01 |
| BCBS Illinois Medical Policies | Allogeneic Pancreas Transplant | 2026-01-01 |